Patent · US Expired

Pentapeptide compounds and uses related thereto

US7256257B2 · kind B2 · utility

39Cited by
42References
52Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 30, 2002
Grant dateAug 14, 2007
Priority date
Expiry dateAug 3, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pentapeptide compounds are disclosed. The compounds have biological activity, e.g., cytotoxicity. Prodrugs having targeting groups and pentapeptide moieities, as well as precursors thereof are also disclosed. For example, precursors having a reactive linker that can serve as a reaction site for joining to a targeting agent, e.g., an antibody, as disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.